Table 6.
Numbers of dogs for which administration of medication represented the first event in the “time to first event” including the type of medication administered and the reasons given for initiating medication. Note that more than 1 reason could be given for administration of medication and therefore the numbers in the “reason for administration” may not add up to the total in the adjacent column
| Indication | Type of medication introduced | Pimobendan | Placebo | Total | ||
|---|---|---|---|---|---|---|
| Number (% of those at risk) | Reason for administration | Number (% of those at risk) | Reason for administration | Number (% of those at risk) | ||
| Cardiac indication | Table 1 medication | 8/178 (4.5%) |
Suspected but not verified CHF = 3 Weakness, collapse anorexia = 3 Persistent tachypnoea = 1 Systolic arterial hypotension = 1 Pulmonary hypertension = 2 Coughing = 2 Poor body condition = 1 Syncope = 2 Inappetence = 1 |
13/176 (7.4%) |
Suspected but not verified CHF = 5 Persistent tachypnoea = 1 Arrhythmia = 2 Coughing = 2 Syncope = 1 Right‐sided heart failure = 1 Persistent sinus tachycardia = 1 |
21/354 (5.9%) |
| Table 2 medication | 1/178 (0.6%) | Coughing | 3/176 (1.7%) |
Coughing = 3 Weakness, collapse, anorexia = 1 |
4/354 (1.1%) | |
| Noncardiac indication | Table 1 medication | 3/178 (1.7%) |
Dental procedure = 2 Neurological disease = 1 |
3/176 (1.7%) |
Sedation/anesthesia = 2 Proteinuria = 1 |
6/354 (1.7%) |
| Table 2 medication | 34/178 (19.1%) |
Coughing = 19 Dermatologic disease = 7 Immune‐mediated disease = 4 Neurologic disease = 2 Endocrinopathy = 1 Unknown = 1 |
32/176 (18.2%) |
Coughing = 19 Neurologic disease = 3 Dermatologic disease = 3 Endocrinopathy = 1 Respiratory disease = 3 Immune‐mediated disease = 1 Behavioral problem = 1 Hypertension = 1 |
66/354 (18.6%) | |
| Total | 46/178 (25.8%) | 51/176 (29.0%) | 97/354 (27.4%) | |||